This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Motzer RJ , Jonasch E , Agarwal N , Bhayani S , Bro WP , Chang SS , Choueiri TK , Costello BA , Derweesh IH , Fishman M , Gallagher TH , Gore JL , Hancock SL , Harrison MR , Kim W , Kyriakopoulos C , Lagrange C , Lam ET , Lau C , Dror Michaelson M , Olencki T , Pierorazio PM , Plimack ER
Kidney Cancer, Version 2.2017: Clinical practice guidelines in oncology
JNCCN Journal of the National Comprehensive Cancer Network. 2017 Jun;15(6) :804-834
PMID: 28596261 URL: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85020412401&doi=10.6004%2fjnccn.2017.0100&partnerID=40&md5=be34de0d3c97c876881a27e45252beb0
AbstractThe NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal carcinoma. These guidelines are developed by a multidisciplinary panel of leading experts from NCCN Member Institutions consisting of medical oncologists, hematologists and hematologic oncologists, radiation oncologists, urologists, and pathologists. The NCCN Guidelines are in continuous evolution and are updated annually or sometimes more often, if new high-quality clinical data become available in the interim.
NotesExport Date: 5 July 2017